- EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein Ilb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 336: 956-961.
- Berkowitz SD, Sane DC, Sigmon KN et al. Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. J Am Coll Cardiol 1998; 32: 311-319.
- Schneider W, Schnaidt M. The platelet adhesion immunofluorescence test: a modification of the platelet suspension immunofluorescence test. Blut 1981; 43: 389-392.
- Kretschmer V, Huss B, Feller K, Ponath N, Kiefel V. Influence of HPA-1a and HLA antibodies on primary hemostasis. Semin Thromb Hemost 1995; 21(suppl 2): 96-102.
- Kereiakes DJ, Essell JH, Abbottsmith CW, Broderick TM, Runyon JP. Abciximab-associated profound thrombocytopenia: therapy with immunoglobulin and platelet transfusion. Am J Cardiol 1996; 78: 1161-1163.
- Berkowitz SD, Harrington RA, Rund RJM, Tcheng JE. Acute profound thrombocytopenia after c7E3 Fab (abciximab) therapy. Circulation 1997; 95: 809-813.
- Frelinger AL III, Cohen I, Plow EF et al. Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J Biol Chem 1990; 265: 6346-6352.
- Bednar B, Bednar RA, Cook JJ et al. Drug-dependent antibodies against GPIIb/IIIa induce thrombocytopenia. Circulation 1996; 94(suppl I): 1-98.
- Jordan RE, Wagner CL, Mascelli MA et al. Preclinical development of c7E3 Fab: a mouse/human chimeric monoclonal antibody fragment that inhibits platelet function by blockade of GPIIb/IIIa receptors with observations on the immunogenicity of c7E3 Fab in humans. In: Horton MA, ed., Adhesion Receptors as Therapeutic Targets. New York: CRC Press, 1996:281-302.
- Chong BH. Heparin-induced thrombocytopenia. Aust N Z J Med 1992; 22: 145-152.
- PRISM-PLUS Investigators. Inhibition of the platelet glycoprotein Ilb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998; 338: 1488-1497.
- Silber S, Gershony G, Schön B, Schön N, Jensen Todd, Schramm W. A novel vascular sealing device for closure of percutaneous arterial access sites. Am J Cardiol 1999; 83: 1248-1252.
Acute severe thrombocytopenia after c7E3 Fab (abciximab) therapy in a patient with unstable angina and stenting of the right coronary artery. Occurrence of subacute stent thrombosis and safe readministration of the GPIIb/IIIa inhibitor tirofiban
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.